Stay updated with breaking news from Advanced Technology Platforms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The home and point-of-care testing platforms target the need for high-performance, low-cost home tests and point-of-care tests that can potentially detect multiple respiratory infections.
The NIH Rapid Acceleration of Diagnostics (RADx) initiative announced today that it has issued contract awards totaling $77.7 million to develop and
/PRNewswire/ -- BioFluidica, a privately held biotechnology company in conjunction with the University of Kansas, today announced they have been awarded a...
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort Share: Insights, lessons learned after a year of transforming COVID-19 testing—a special journal issue One-year into implementation of the National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx) initiative, the Institute of Electrical and Electronics Engineers (IEEE) Open Journal of Engineering in Medicine and Biology has dedicated a special April 29...
HIN A research team funded by the National Institutes of Health has launched a study to assess performance and usability of a smartphone app paired with the Quidel QuickVue At-Home COVID-19 Test, which just received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for use with a prescription. The home test was supported by NIH through the Rapid Acceleration of Diagnostics (RADx) initiative, which has spurred the development and commercial availability of millions of COVID-19 tests over the past year. More than 200 participants have already enrolled in the study ...